Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

Nauck Michael A.; Kreiner Eskil; Rasmussen Soren; Saevereid Hans A.; Buse John B.

首页> 外文期刊>Diabetes care >Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

【24h】

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

机译：对Nauck等人评论的回应。 Liraglutide与安慰剂对患有2型糖尿病患者患者的患者患者的影响，在患有2型糖尿病患者中的心血管事件中的患者随机试验。 2019年糖尿病护理; 42：1912-1920

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetes care》 |2020年第2期|共2页
作者
Nauck Michael A.; Kreiner Eskil; Rasmussen Soren; Saevereid Hans A.; Buse John B.;
展开▼
作者单位

Ruhr Univ St Josef Hosp Diabet Div Bochum Germany;

Novo Nordisk AS Soborg Denmark;

Novo Nordisk AS Soborg Denmark;

Novo Nordisk AS Soborg Denmark;

Univ N Carolina Sch Med Chapel Hill NC 27515 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920 [J] . Nauck Michael A., Kreiner Eskil, Rasmussen Soren, Diabetes care . 2020,第2期

机译：对Nauck等人评论的回应。 Liraglutide与安慰剂对患有2型糖尿病患者患者的患者患者的影响，在患有2型糖尿病患者中的心血管事件中的患者随机试验。 2019年糖尿病护理; 42：1912-1920
2. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial [J] . Nauck Michael A., Ghorbani Marie Louise Muus, Kreiner Eskil, Diabetes care . 2019,第10期

机译：Liraglutide与安慰剂对患有2型糖尿病患者急性胆囊或胆汁病事件的影响，该糖尿病患者心血管事件高患者随机试验
3. Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes. Diabetes Care 2019;42:1088-1094 [J] . Pilemann-Lyberg Sascha, Hansen Tine Willum, Rossing Peter Diabetes care . 2019,第12期

机译：对Pilemann-Lyberg等人评论的回应。尿酸是1型糖尿病患者肾功能，心血管事件和死亡率下降的独立危险因素。糖尿病护理2019; 42：1088-1094
4. Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920 [O] . Michael A. Nauck, Eskil Kreiner, Søren Rasmussen, 2020

机译：对Nauck等人评论的回应。 Liraglutide与安慰剂对患有2型糖尿病患者患者的患者患者的影响在患有2型糖尿病患者中的心血管事件中的患者随机试验。 2019年糖尿病护理; 42：1912-1920
5. Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920 [O] . Michael A. Nauck, Eskil Kreiner, Søren Rasmussen, 2020

机译：对Nauck等人评论的回应。 Liraglutide与安慰剂对患有2型糖尿病患者患者的患者患者的影响，在患有2型糖尿病患者中的心血管事件中的患者随机试验。 2019年糖尿病护理; 42：1912-1920

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

著录项

相似文献

相关主题

期刊订阅